Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
63 studies found for:    Kaohsiung, Taiwan HCC
Show Display Options
Rank Status Study
1 Completed
Has Results
Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration
Condition: Hepatocellular Carcinoma
2 Completed Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization
Condition: Hepatocellular Carcinoma
3 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Hepatocellular Carcinoma
Intervention: Drug: peginterferon alpha-2a and ribavirin
4 Unknown  Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
Conditions: Cirrhosis;   Hepatocellular Carcinoma
5 Completed Tumor Growth Factors in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Biological: tumor growth factor concentration
6 Completed Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Conditions: Hepatitis B;   Hepatocellular Carcinoma;   Chronic Liver Disease
Intervention: Genetic: Polymorphism of IL-1 beta and TNF-alpha
7 Recruiting Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Metastasis;   Invasion
Intervention: Drug: Colchicine
8 Recruiting Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients
Condition: Hepatocellular Carcinoma
Intervention: Other: not interventional study
9 Completed Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication
Conditions: Hepatocellular Carcinoma;   Hepatitis B Virus
10 Completed Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin
11 Completed Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization
Condition: Hepatocellular Carcinoma
12 Completed Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Genetic: Polymorphisms of HSP70 and TNF promoter
13 Unknown  Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation
Condition: Chronic HBV With Severe Exacerbation
Interventions: Drug: Tenofovir;   Drug: lamivudine
14 Unknown  Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease
Conditions: Chronic Liver Disease;   Hepatocellular Carcinoma
Interventions: Genetic: TNF-alpha and HBV genotype;   Other: TNF-alpha and HBV genotypes
15 Terminated A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Adefovir Dipivoxil and Lamivudine
16 Completed Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease
Conditions: Hepatitis;   Liver Cirrhosis;   Hepatocellular Carcinoma
17 Recruiting Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Administer 40mg Lipotecan at D1, D8, D15 of each cycle.
18 Recruiting Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment
Conditions: Liver Fibroses;   HepatoCellular Carcinoma;   Cryoglobulinemia;   Metabolic Disease;   Diabetes Mellitus
Intervention: Other: Observation only
19 Completed Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease
Conditions: Fibrosis;   Chronic Liver Disease
Interventions: Genetic: cytokine;   Genetic: cytokine polymorphisms;   Genetic: cytokine polymorphism
20 Not yet recruiting DAA in the Risk of Recurrence After Curative Treatment of HCC
Condition: Hepatocellular Carcinoma
Interventions: Drug: Ledipasvir 90mg/Sofosbuvir 400 mg;   Drug: Ribavirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.